US Patent 11505540 Salts of a Pim kinase inhibitor
Patent 11505540 was granted and assigned to Incyte on November, 2022 by the United States Patent and Trademark Office.
All edits
Edits on 25 Jul, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
0
Edits on 16 Oct, 2023
Golden AI
Edits made to:
Infobox (+10 properties)
Infobox
Patent Inventor Names
Changsheng Zheng0
Chongsheng Eric Shi0
Ganfeng Cao0
Lei Qiao0
Michael Xia0
Qiyan Lin0
Qun Li0
Vaqar Sharief0
Yongchun Pan0
Zhongjiang Jia0
Edits on 24 Apr, 2023
Golden AI
Edits on 29 Mar, 2023
Golden AI
Edits on 26 Mar, 2023
Golden AI
Infobox
Patent Citations
Edits on 22 Mar, 2023
Golden AI
Infobox
Golden AI
Edits on 25 Nov, 2022
Golden AI
Edits made to:
Infobox (+15 properties)
Article (+423 characters)
US Patent 11505540 Salts of a Pim kinase inhibitor
Article
The present invention relates to salt forms of the Pim kinase inhibitor N-{(7R)-4-[(3R,4R,5S)-3-amino-4-hydroxy-5-methylpiperidin-1-yl]-7-hydroxy-6,7-dihydro-5H-cyclopenta[b]pyridin-3-yl}-6-(2,6-difluorophenyl)-5-fluoropyridine-2-carboxamide, including methods of preparation thereof, and intermediates in the preparation thereof, where the compound is useful in the treatment of Pim kinase-related diseases such as cancer.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
115055400
Date of Patent
November 22, 2022
0Patent Application Number
171478770
Date Filed
January 13, 2021
0Patent Citations
0
Patent Primary Examiner
Find more entities like US Patent 11505540 Salts of a Pim kinase inhibitor
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.